Prevalence and Progression of Macular Atrophy in Eyes with Neovascular Age-Related Macular Degeneration in the Phase 2 Ladder Trial of the Port Delivery System with Ranibizumab

Glenn J Jaffe,Briana Cameron, David Kardatzke,Jane Ives,Giulio Barteselli,Shamika Gune

Ophthalmology Retina（2022）

引用 0|浏览7

暂无评分

摘要

In the phase 2 Ladder trial, there was no evidence of worse MA with the PDS compared with that with monthly intravitreal ranibizumab 0.5-mg injections. Larger trials focusing on MA are needed to confirm this finding.

查看译文

关键词

Macular atrophy,Neovascular AMD,Phase 2,Port Delivery System,Ranibizumab

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要